Wall St set for $1bn fee bonanza from pharma mega-deal

656

Drugmakers Bristol-Myers Squibb and Celgene will pay about $1bn in fees to seal their $90bn tie-up, including more than $300m to their financial advisers, in one of the most lucrative advisory assignments ever recorded on Wall Street

Source: https://www.ft.com/content/7dc80cda-27d9-11e9-88a4-c32129756dd8